SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED PURSUANT TO RULE 13d-2(b)
(AMENDMENT NO. _)
Telaxis Communications Corporation
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, Par Value $.01 Per Share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
879202 10 9
- --------------------------------------------------------------------------------
(CUSIP Number)
March 21, 2000
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ X ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
Page 1 of 5 Pages
<PAGE>
CUSIP NO. 879202 10 9 Page 2 of 6 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
SVM STAR VENTURES MANAGEMENT GMBH NO. 3
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Germany
5. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
VOTING POWER
2,834,216
6. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SHARED VOTING POWER
0
7. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
DISPOSITIVE POWER
2,834,216
8. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SHARED DISPOSITIVE POWER
0
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,834,216
10. CHECK FOR BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
18.4%
12. TYPE OF REPORTING PERSON
IN
<PAGE>
CUSIP NO. 879202 10 9 Page 3 of 6 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Meir Barel
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Germany
5. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
VOTING POWER
2,834,216
6. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SHARED VOTING POWER
0
7. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SOLE
DISPOSITIVE POWER
2,834,316
8. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
SHARED DISPOSITIVE POWER
0
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,834,216*
Dr. Barel expressly disclaims beneficial ownership of all shares
except for 22,222 shares held in trust for the benefit of Dr. Barel.
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
18.4%
12. TYPE OF REPORTING PERSON
IN
<PAGE>
CUSIP NO. 879202 10 9 Page 4 of 6 Pages
- --------------------------------------------------------------------------------
Item 1. (a) Name of Issuer:
Telaxis Communications Corporation.
(b) Address of Issuer's Principal Executive Offices:
20 Industrial Drive East,
South Deerfield, Massachusetts 01373.
Item 2. (a) Name of Person Filing:
(i) SVM Star Ventures Management GmbH No. 3 ("Star Germany"),
a German company which manages investments primarily in
securities of Israeli and Israeli-related companies. Star
Germany manages the affairs of SVE Star Ventures Enterprises
No. V, a German Civil Law Partnership, SVE Star Ventures
Managementgesellschaft mbh Nr. 3 & Co. Betelligungs KG Nr. 2,
SVE Star Ventures Enterprises No. VII, a German Civil Law
Partnership, and Star Growth Enterprise, a German Civil Law
Partnership. The sole director and primary owner of Star
Germany is Dr. Meir Barel.
(ii) Dr. Meir Barel ("Dr. Barel") is a German citizen who is a
professional investment manager residing in Munich, Germany.
(b) Address of Principal Business Office or, if none, Residence:
The address of each reporting entity/person's principal
business office is:
(i) SVM Star Ventures Management
GmbH No. 3, Possartstrasse 9, D-81679
Munich, Germany; and
(ii) Dr. Meir Barel, c/o SVM Star Ventures Management,
GmbH No. 3, Possartstrasse 9, D-81679
Munich, Germany.
(c) Citizenship:
(i) Star Germany is a German company;
(ii) Dr. Barel is a German citizen.
(d) Title of Class of Securities:
The title of the class of
securities for which this Schedule is being filed is Common
Stock, $.01 par value ("Common Stock").
(e) CUSIP Number: The Issuer's CUSIP number is 879202.
Item 3. If this statement is filed pursuant to ss.ss. 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable.
<PAGE>
CUSIP NO. 879202 10 9 Page 5 of 6 Pages
- --------------------------------------------------------------------------------
Item 4. Ownership:
(a) Each reporting person may be deemed to beneficially own the
following shares of the Issuer's outstanding Common Stock:
(i) Star Germany is deemed to beneficially own 2,834,216
shares of Common Stock; and
(ii) Dr. Barel is deemed to beneficially own 2,834,216 shares
of Common Stock. Barel expressly disclaims beneficial
ownership of all shares except for 22,222 shares held in trust
by Star Germany for the benefit of Dr. Barel.
(b) Each reporting entity/person is deemed to beneficially own the
following percent of the Common Stock:
(i) Star Germany owns 18.4%; and
(ii) Dr. Barel owns 18.4%.
(c) The number of shares as to which the reporting person has (i)
sole power to vote or to direct the vote; (ii) shared power to
vote or to direct the vote; (iii) sole power to dispose or to
direct the disposition of; and (iv) shared power to dispose or
to direct the disposition of is as follows:
(i) Star Germany has the (i) sole power to vote or to direct
the vote of 2,834,216 shares of Common Stock; (ii) shared
power to vote or to direct the vote of 0 shares of Common
Stock; (iii) sole power to dispose or to direct the
disposition of 2,834,216 shares of Common Stock; and (iv)
shared power to dispose or to direct the disposition of 0
shares of Common Stock; and
(ii) Dr. Barel has the (i) sole power to vote or to direct the
vote of 2,834,216 shares of Common Stock; (ii) shared power to
vote or to direct the vote of 0 shares of Common Stock; (iii)
sole power to dispose or to direct the disposition of
2,834,216 shares of Common Stock; and (iv) shared power to
dispose or to direct the disposition of 0 shares of Common
Stock. Dr. Barel expressly disclaims beneficial ownership of
all shares except for 22,222 shares held in trust for the
benefit of Dr. Barel.
Item 5. Ownership of Five Percent or Less of a Class: Not applicable.
Item 6. Ownership of more than Five Percent on Behalf of Another
Person: Not applicable.
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security Being Reported on By the Parent Holding
Company or Control Person: Not applicable.
Item 8. Identification and Classification of Members or the Group:
Not applicable.
Item 9. Notice of Dissolution of Group: Not applicable.
<PAGE>
CUSIP NO. 879202 10 9 Page 6 of 6 Pages
- --------------------------------------------------------------------------------
Item 10. Certifications: By signing below I certify that, to the
best of my knowledge and belief, the securities referred to
above were not acquired and are not held for the purpose of or
with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction
having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
SVM Star Ventures Management
GmbH No. 3
Date: March 21, 2000 By: /s/ Dr. Meir Barel
----------------------
Dr. Meir Barel, Director
Date: March 21, 2000 By: /s/ Dr. Meir Barel
----------------------
Dr. Meir Barel
